EHL service area
Bone & Joint
Topics on this page come from disease information published by EHL BIO and connect to assessment at the hospital in Korea.
Korean regenerative-medicine law
Korea provides a regulated advanced regenerative-medicine treatment pathway
Korea's amended law, effective 21 February 2025, allows designated advanced regenerative-medicine institutions to submit treatment plans for committee review and charge for treatment delivered under a plan found suitable.
The law does not automatically authorise every stem-cell type for every disease. Access depends on the institution's status, cell type, condition, a suitable reviewed plan and individual patient assessment.
Overview from EHL
EHL presents degenerative and rheumatoid arthritis around cartilage, inflammation and joint function.
Conditions (2)
EHL BIO information and approach
Degenerative Osteoarthritis
EHL BIO presents degenerative arthritis as a regenerative-medicine area centred on cartilage, inflammation and joint function.
Explore EHL's approach
EHL BIO information and approach
Rheumatoid Arthritis
EHL BIO includes rheumatoid arthritis within its autoimmune-disease information, focusing on immune balance and the immune-modulating characteristics of adult stem cells.
Explore EHL's approachEHL research progress in this area
Why choose EHL
- EHL credentialEHL Cell Clinic designated as the first clinic-level advanced regenerative-medicine institutionEHL source
- EHL credentialHuman cell management business licence from Korea's MFDSEHL source
- EHL credentialEHL BIO GMP cell-manufacturing centreEHL source
- EHL credentialPatent for fat-harvesting and SVF separation kitEHL source
- EHL credentialRegenerative-medicine partnership with Gangnam Severance HospitalEHL source
- EHL credentialKorean Minister of Health and Welfare awardEHL source
- EHL credentialIR52 Jang Young-sil award for technology innovationEHL source
Service steps
- 1Send history and test results for consultation
- 2Individual physician assessment
- 3Cell collection at the hospital in Korea
- 4Culture and quality control in the GMP lab
- 5Administration under a reviewed plan
- 6Follow-up with the clinical team
What to prepare
- Treatment history and current medications
- Recent blood tests, imaging or physician reports
- The goals you want to discuss
- Passport and readiness to travel to Seoul
Suitability depends on physician assessment; results vary between individuals.